Published in Transplantation on March 15, 2012
Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med (2013) 0.93
Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model. Bone Marrow Transplant (2013) 0.91
The hematopoietic system in the context of regenerative medicine. Methods (2015) 0.84
The need for inducing tolerance in vascularized composite allotransplantation. Clin Dev Immunol (2012) 0.79
Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties. PLoS One (2015) 0.75
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med (2003) 7.78
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Regulatory T cells in transplantation tolerance. Nat Rev Immunol (2003) 6.42
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 5.48
"Infectious" transplantation tolerance. Science (1993) 4.98
Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature (1984) 4.26
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med (1989) 3.34
Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med (1981) 2.39
A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes (2002) 2.24
Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol (1998) 2.10
Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med (1985) 2.00
Induction of classical transplantation tolerance in the adult. J Exp Med (1989) 1.91
Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol (1994) 1.77
On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol (1980) 1.62
Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol (2002) 1.50
T cell suppression in transplantation tolerance through linked recognition. J Immunol (1996) 1.45
Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant (2010) 1.36
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol (1995) 1.28
Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med (1997) 1.27
Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol (2004) 1.20
Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen. Nature (1974) 1.20
CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance. Transplantation (2003) 1.19
Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation (1996) 1.18
Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology (1996) 1.16
Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med (1990) 1.15
Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol (1996) 1.14
Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells. Proc Natl Acad Sci U S A (2004) 1.11
Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. J Clin Invest (1999) 1.05
NK cell tolerance in mixed allogeneic chimeras. J Immunol (2003) 0.98
Molecular mechanisms of CD40 signaling. Arch Immunol Ther Exp (Warsz) (2001) 0.96
Tolerance of Sk-incompatible skin grafts. Nature (1973) 0.94
Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. Transplantation (1986) 0.92
Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation. Transplantation (2007) 0.92
The role of T cell apoptosis in transplantation tolerance. Curr Opin Immunol (2000) 0.91
A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases. Kidney Int (1998) 0.90
T and B cell cooperation: a dance of life and death. Transplantation (2005) 0.87
Malignancy. Surg Clin North Am (1994) 0.87
Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A (2007) 0.85
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood (2007) 0.83
Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen. Transplantation (1992) 0.82
T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation (2001) 0.81
Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras. Am J Transplant (2007) 0.80
CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. J Immunol (2002) 0.79
Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int (1994) 0.77
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest (2008) 4.13
Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity (2011) 3.75
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Integrated 3D-printed reactionware for chemical synthesis and analysis. Nat Chem (2012) 3.23
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest (2003) 2.54
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol (2012) 2.53
Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res (2004) 2.50
Retracted FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest (2011) 2.44
Surface magnetoelectric effect in ferromagnetic metal films. Phys Rev Lett (2008) 2.17
Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet (2011) 2.13
Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat Med (2009) 2.10
SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res (2005) 2.07
Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression. Cell (2012) 2.06
IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol (2003) 2.03
Racial and Ethnic Disparities in Hospital Readmissions After Delivery. Obstet Gynecol (2015) 2.01
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol (2004) 2.00
Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res (2006) 1.98
Dehalococcoides mccartyi gen. nov., sp. nov., obligately organohalide-respiring anaerobic bacteria relevant to halogen cycling and bioremediation, belong to a novel bacterial class, Dehalococcoidia classis nov., order Dehalococcoidales ord. nov. and family Dehalococcoidaceae fam. nov., within the phylum Chloroflexi. Int J Syst Evol Microbiol (2012) 1.93
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun (2004) 1.82
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res (2003) 1.81
Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation (2006) 1.80
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest (2015) 1.74
Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. Metabolomics (2011) 1.73
Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci (2004) 1.71
Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate. Nature (2011) 1.67
Synthesis and electromagnetic, microwave absorbing properties of core-shell Fe3O4-poly(3, 4-ethylenedioxythiophene) microspheres. ACS Appl Mater Interfaces (2011) 1.62
Induction of regulatory T cells by physiological level estrogen. J Cell Physiol (2008) 1.59
Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med (2005) 1.53
A novel cell segmentation method and cell phase identification using Markov model. IEEE Trans Inf Technol Biomed (2009) 1.51
Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation (2013) 1.50
[A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old]. Zhonghua Liu Xing Bing Xue Za Zhi (2005) 1.48
Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J Immunol (2006) 1.47
Corticofugal modulation of initial sound processing in the brain. J Neurosci (2008) 1.46
The linker domain of the Ha-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J Biol Chem (2001) 1.44
Compromised small-world efficiency of structural brain networks in schizophrenic patients and their unaffected parents. Neurosci Bull (2015) 1.43
ARGONAUTE10 and ARGONAUTE1 regulate the termination of floral stem cells through two microRNAs in Arabidopsis. PLoS Genet (2011) 1.40
An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma. Clin Res Hepatol Gastroenterol (2013) 1.39
A Novel Combined-Catheter to Monitor Left and Right Atrial Pressures: A Simple and Reliable Method for Pediatric Cardiac Surgery. Pediatr Crit Care Med (2016) 1.39
The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell Metab (2009) 1.38
Detecting cytokine release from single T-cells. Anal Chem (2009) 1.37
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood (2011) 1.35
A plasma membrane receptor kinase, GHR1, mediates abscisic acid- and hydrogen peroxide-regulated stomatal movement in Arabidopsis. Plant Cell (2012) 1.33
A three-dimensional carbon nanotube/graphene sandwich and its application as electrode in supercapacitors. Adv Mater (2010) 1.31
Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation. PLoS One (2010) 1.31
Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood (2006) 1.29
Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells. Exp Hematol (2006) 1.28
TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J Immunol (2008) 1.26
Integrating sensing hydrogel microstructures into micropatterned hepatocellular cocultures. Langmuir (2009) 1.24
A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins. Stem Cells (2007) 1.23
Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia (2006) 1.23
Waiting for organ transplantation: results of an analysis by an Institute of Medicine Committee. Biostatistics (2003) 1.23
Transplantation of the hand, face, and composite structures: evolution and current status. Clin Plast Surg (2007) 1.23
αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.22
New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol (2012) 1.21
Dehalogenimonas lykanthroporepellens gen. nov., sp. nov., a reductively dehalogenating bacterium isolated from chlorinated solvent-contaminated groundwater. Int J Syst Evol Microbiol (2009) 1.20
Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol (2004) 1.20
Shotgun proteomics analysis of hibernating arctic ground squirrels. Mol Cell Proteomics (2009) 1.20
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer (2011) 1.19
Characterizing changes in student empathy throughout medical school. Med Teach (2012) 1.19
Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellum. Dev Biol (2008) 1.18
Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis. Cancer Res (2012) 1.18
Facile synthesis of graphene nanosheets via Fe reduction of exfoliated graphite oxide. ACS Nano (2010) 1.17
DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res (2012) 1.17
Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun (2002) 1.16
Coordinated regulation of apical hook development by gibberellins and ethylene in etiolated Arabidopsis seedlings. Cell Res (2012) 1.15
Cold-induced RNA-binding proteins regulate circadian gene expression by controlling alternative polyadenylation. Sci Rep (2013) 1.14
Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. OMICS (2011) 1.13
Structure of the VirB4 ATPase, alone and bound to the core complex of a type IV secretion system. Proc Natl Acad Sci U S A (2012) 1.12
TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. Am J Pathol (2011) 1.12
Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice. Hepatology (2013) 1.11
Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS One (2009) 1.10
Development of an aptamer beacon for detection of interferon-gamma. Anal Chem (2010) 1.10
Design and synthesis of boronic-acid-labeled thymidine triphosphate for incorporation into DNA. Nucleic Acids Res (2007) 1.09
Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55. Cancer Res (2007) 1.09
Human stem cell grafts as therapies for motor neuron disease. Expert Opin Biol Ther (2008) 1.08
Nitric oxide inhibits autophagy in human chondrocytes: comment on the article by Sasaki et al. Arthritis Rheum (2013) 1.08
Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China. Can J Gastroenterol (2009) 1.08
Federal nutrition program changes and healthy food availability. Am J Prev Med (2012) 1.07
Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp Mol Pathol (2009) 1.07
Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One (2012) 1.07
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan. J Immunol (2005) 1.07
Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: potential involvement of very small embryonic-like cells. Transplantation (2010) 1.07
CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo. Blood (2010) 1.07
Flt3-ligand treatment prevents diabetes in NOD mice. Diabetes (2004) 1.06
Surgical and transcatheter closure of right pulmonary artery to left atrial fistula. J Card Surg (2011) 1.05